ABVC BioPharma
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $-795 | $795 | $0 |
Gross Profit | -92 | -795 | 795 | -80 |
EBITDA | -1,548 | -3,565 | -1,955 | -2,098 |
EBIT | -1,640 | -3,779 | -2,051 | -2,179 |
Net Income | -1,560 | -3,562 | -2,042 | -2,257 |
Net Change In Cash | 0 | -795 | 795 | 0 |
Free Cash Flow | -894 | -1,419 | -133 | -894 |
Cash | 140 | 681 | 192 | 1,076 |
Basic Shares | 25,448 | 23,256 | 23,256 | 17,386 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $795 | $509 | $152 | $969 |
Gross Profit | 795 | 508 | -149 | 683 |
EBITDA | -7,432 | -4,342 | -6,330 | -15,196 |
EBIT | -7,936 | -4,543 | -6,711 | -15,220 |
Net Income | -7,908 | -4,902 | -7,788 | -16,423 |
Net Change In Cash | 795 | 509 | 152 | 969 |
Free Cash Flow | -2,986 | -1,809 | -4,208 | -7,518 |
Cash | 681 | 863 | 716 | 1,391 |
Basic Shares | 23,256 | 11,673 | 4,335 | 3,166 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.05 |
2025-06-30 | -$0.13 |
2025-03-31 | $0.02 |
2024-09-30 | -$0.01 |